25.45
price down icon0.43%   -0.11
 
loading

Xoma Corporation (XOMAO) 最新ニュース

pulisher
04:50 AM

Short Squeeze: Will XOMA Royalty Corporation(X0M) stock rise with strong economyJuly 2025 Rallies & Free Accurate Trade Setup Notifications - DonanımHaber

04:50 AM
pulisher
04:39 AM

Can XOMA Royalty Corporation stock outperform in 2025 bull marketQuarterly Performance Summary & AI Forecasted Entry and Exit Points - DonanımHaber

04:39 AM
pulisher
03:38 AM

Can XOMA Royalty Corporation(X0M) stock sustain institutional flowsWeekly Trade Summary & Fast Moving Market Watchlists - DonanımHaber

03:38 AM
pulisher
Dec 18, 2025

Can XOMA Royalty Corporation stock double in next 5 yearsWeekly Trade Review & Free Risk Controlled Daily Trade Plans - Улправда

Dec 18, 2025
pulisher
Dec 18, 2025

Will XOMA Royalty Corporation (X0M1) stock profit from fiscal stimulusM&A Rumor & Risk Adjusted Buy and Sell Alerts - Улправда

Dec 18, 2025
pulisher
Dec 16, 2025

Jefferies downgrades Generation Bio stock to Hold as XOMA acquisition announced By Investing.com - Investing.com South Africa

Dec 16, 2025
pulisher
Dec 16, 2025

Generation Bio is latest Mass. biotech to be acquired by Xoma - The Business Journals

Dec 16, 2025
pulisher
Dec 16, 2025

XOMA to buy struggling Generation Bio - The Pharma Letter

Dec 16, 2025
pulisher
Dec 16, 2025

Jefferies downgrades Generation Bio stock to Hold as XOMA acquisition announced - Investing.com Nigeria

Dec 16, 2025
pulisher
Dec 16, 2025

‘Zombie’ biotech buyer Xoma to acquire Generation Bio - Yahoo Finance

Dec 16, 2025
pulisher
Dec 16, 2025

XOMA Strikes Deal To Acquire Generation Bio, Expanding Royalty Portfolio - Nasdaq

Dec 16, 2025
pulisher
Dec 15, 2025

XOMA Royalty to Acquire Generation Bio - citybiz

Dec 15, 2025
pulisher
Dec 15, 2025

Generation Bio Announces Merger with XOMA Royalty - TipRanks

Dec 15, 2025
pulisher
Dec 15, 2025

Xoma Royalty enters into agreement to acquire Generation Bio - marketscreener.com

Dec 15, 2025
pulisher
Dec 15, 2025

XOMA Royalty Corporation to Acquire Generation Bio Co. in Cash Transaction with Milestone and Royalty Opportunities - Quiver Quantitative

Dec 15, 2025
pulisher
Dec 15, 2025

Generation Bio (NASDAQ: GBIO) agrees to $4.29 sale to XOMA Royalty plus CVR - Stock Titan

Dec 15, 2025
pulisher
Dec 15, 2025

Investors Don't See Light At End Of XOMA Royalty Corporation's (NASDAQ:XOMA) Tunnel - simplywall.st

Dec 15, 2025
pulisher
Dec 15, 2025

Generation Bio (GBIO) to be acquired in planned XOMA tender offer - Stock Titan

Dec 15, 2025
pulisher
Dec 15, 2025

FY2025 EPS Estimates for XOMA Royalty Reduced by Analyst - MarketBeat

Dec 15, 2025
pulisher
Dec 13, 2025

XOMA Royalty Corporation: A Deep Dive into a Biotech Royalty Aggregator (12/13/2025) - Markets Financial Content

Dec 13, 2025
pulisher
Dec 13, 2025

BVF Inc. IL Has $65.28 Million Stock Position in XOMA Royalty Corporation $XOMA - MarketBeat

Dec 13, 2025
pulisher
Dec 12, 2025

Why (XOMAO) Price Action Is Critical for Tactical Trading - news.stocktradersdaily.com

Dec 12, 2025
pulisher
Dec 12, 2025

Price-Driven Insight from (XOMA) for Rule-Based Strategy - news.stocktradersdaily.com

Dec 12, 2025
pulisher
Dec 12, 2025

XOMA stock maintains Buy rating at Benchmark despite partner’s trial setback - Investing.com

Dec 12, 2025
pulisher
Dec 12, 2025

XOMA: HC Wainwright Maintains Buy Rating, Lowers Price Target to $97 | XOMA Stock News - GuruFocus

Dec 12, 2025
pulisher
Dec 11, 2025

Leerink Partners lowers XOMA stock price target on RZ358 trial failure By Investing.com - Investing.com South Africa

Dec 11, 2025
pulisher
Dec 11, 2025

HC Wainwright & Co. Maintains XOMA Royalty (XOMA) Buy Recommendation - Nasdaq

Dec 11, 2025
pulisher
Dec 11, 2025

HC Wainwright & Co. Maintains XOMA Royalty CorporationPreferred Stock (XOMAP) Buy Recommendation - Nasdaq

Dec 11, 2025
pulisher
Dec 11, 2025

Why two Bay Area companies' stocks tumbled on a drug's clinical failure - The Business Journals

Dec 11, 2025
pulisher
Dec 11, 2025

XOMA stock price target lowered to $97 by H.C. Wainwright - Investing.com Australia

Dec 11, 2025
pulisher
Dec 11, 2025

XOMA Royalty Corporation (NASDAQ:XOMA) Receives Average Rating of "Hold" from Brokerages - MarketBeat

Dec 11, 2025
pulisher
Dec 11, 2025

XOMA: Leerink Partners Lowers Price Target, Reiterates Outperfor - GuruFocus

Dec 11, 2025
pulisher
Dec 11, 2025

Why Is XOMA Royalty Stock Sinking Thursday? - Benzinga

Dec 11, 2025
pulisher
Dec 11, 2025

Leerink Partners lowers XOMA stock price target on RZ358 trial failure - Investing.com

Dec 11, 2025
pulisher
Dec 10, 2025

LUCID CAPITAL MARKETS Initiates Coverage of XOMA Royalty CorporationPreferred Stock (XOMAP) with Buy Recommendation - Nasdaq

Dec 10, 2025
pulisher
Dec 09, 2025

LUCID CAPITAL MARKETS Initiates Coverage of XOMA Royalty (XOMA) with Buy Recommendation - Nasdaq

Dec 09, 2025
pulisher
Dec 09, 2025

Lucid Capital Markets initiates coverage on XOMA stock with Buy rating - Investing.com Canada

Dec 09, 2025
pulisher
Dec 09, 2025

XOMA Royalty (XOMA): New Buy Rating Initiated by Lucid Capital M - GuruFocus

Dec 09, 2025
pulisher
Dec 09, 2025

Xoma initiated with a Buy at Lucid Capital - TipRanks

Dec 09, 2025
pulisher
Dec 08, 2025

CEO’s Bold Move: Massive Investment in Xoma Stock! - TipRanks

Dec 08, 2025
pulisher
Dec 08, 2025

Insider Buying: XOMA Royalty (NASDAQ:XOMA) CEO Acquires 100,000 Shares of Stock - MarketBeat

Dec 08, 2025
pulisher
Dec 08, 2025

XOMA Royalty Corp CEO Owen Hughes Acquires 100,000 Depositary Shares - TradingView

Dec 08, 2025
pulisher
Dec 07, 2025

Xoma Royalty Expands Portfolio Through Mural Oncology Acquisition - AD HOC NEWS

Dec 07, 2025
pulisher
Dec 06, 2025

XOMA Royalty completes acquisition of Mural Oncology for $2.035 per share - Investing.com Nigeria

Dec 06, 2025
pulisher
Dec 06, 2025

XOMA Royalty completes acquisition of Mural Oncology By Investing.com - Investing.com Nigeria

Dec 06, 2025
pulisher
Dec 05, 2025

Xoma Completes Acquisition of Mural Oncology - TipRanks

Dec 05, 2025
pulisher
Dec 05, 2025

Xoma announces closing of transaction to acquire Mural Oncology - TipRanks

Dec 05, 2025
pulisher
Dec 05, 2025

XOMA Royalty completes acquisition of Mural Oncology for $2.035 per share By Investing.com - Investing.com South Africa

Dec 05, 2025
pulisher
Dec 05, 2025

Mural Oncology Announces Effectiveness of Scheme of Arrangement and Completion of Acquisition - Research Tree

Dec 05, 2025
pulisher
Dec 05, 2025

Xoma Royalty announces closing of transaction to acquire Mural Oncology plc - marketscreener.com

Dec 05, 2025
pulisher
Dec 05, 2025

XOMA Royalty Corporation Completes Acquisition of Mural Oncology plc Under Irish High Court Sanctioned Scheme - Quiver Quantitative

Dec 05, 2025
pulisher
Dec 05, 2025

XOMA Royalty Announces Closing of Transaction to Acquire Mural Oncology plc - The Manila Times

Dec 05, 2025
pulisher
Dec 05, 2025

XOMA Royalty (Nasdaq: XOMA) completes $2.035 per share Mural Oncology takeover - Stock Titan

Dec 05, 2025
pulisher
Dec 05, 2025

XOMA Royalty completes acquisition of Mural Oncology - Investing.com India

Dec 05, 2025
$38.43
price up icon 0.31%
$97.31
price down icon 0.33%
$31.50
price down icon 0.66%
$91.46
price down icon 0.15%
biotechnology ONC
$307.02
price up icon 0.32%
$166.55
price down icon 16.08%
大文字化:     |  ボリューム (24 時間):